Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Edaravone and Dexborneol Concentrated Solution for Injection

Approval Number

国药准字H20200007

Company海南先声药业有限公司

Registration Date

July 29, 2020

Drug Information

Generic Name

依达拉奉右莰醇注射用浓溶液

Brand Name

先必新

Dosage Form

注射剂

Strength

5ml:依达拉奉10mg与右莰醇2.5mg

Drug Type

化学药品

Registration Date

July 29, 2020

Company Information

Applicant Company

Company Name海南先声药业有限公司

Company Address

江苏省南京江北新区华康路99号

Manufacturing Company

Company Name

先声药业有限公司;海南先声药业有限公司

Company Address

南京江北新区华康路99号；海南省海口市秀英区药谷三路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy